
Gatoverine 135mg Tablet
Marketer
Cmg Biotech Pvt Ltd
Salt Composition
Mebeverine (135mg)
Overview Gatoverine 135mg Tablet
Methylergonovine 135mg tablets are a prescription medication indicated for the management and symptomatic relief of irritable bowel syndrome, encompassing abdominal pain and cramping, flatulence, distension, and altered bowel patterns. This medication achieves its therapeutic effect by relaxing intestinal musculature and alleviating spasms. Dosage and treatment duration for Methylergonovine 135mg tablets should strictly adhere to your physician's instructions. Ingestion should be whole, with water, ideally 20 minutes prior to meals to mitigate postprandial symptoms. Comprehensive disclosure of all concurrent medications is crucial, as interactions may occur. Consistent adherence to the prescribed treatment regimen is vital; premature cessation may result in symptom recurrence and potential disease exacerbation. Auxiliary lifestyle adjustments, including a high-fiber diet, increased hydration, and regular physical activity, can enhance therapeutic outcomes. While generally well-tolerated, potential adverse effects, albeit rare, may include cutaneous eruptions, syncope, or angioedema. Immediate cessation and medical consultation are imperative should respiratory compromise or facial, neck, lingual, or pharyngeal swelling arise. Prior to initiating therapy, patients with hepatic or renal impairment should inform their prescribing physician. Similarly, pregnant or lactating women require physician consultation before commencing treatment.
Primary Ingredients of Gatoverine 135mg Tablet
No text was provided to rewrite.
Uses of Gatoverine 135mg Tablet
Managing irritable bowel syndrome
Major Benefits of Gatoverine 135mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Swallow the Gatoverine 135mg tablet whole; do not crush, chew, or break it. Administer this medication on an empty stomach.
Common Side effects of Gatoverine 135mg Tablet:
- Fainting
- Skin rash
- Angioedema (swelling of deeper layers of skin)
How to use Gatoverine 135mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire Gatoverine 135mg tablet without chewing, crushing, or breaking it. Administer this medication on an empty stomach.
How Gatoverine 135mg Tablet works:
Intestinal muscle relaxant Gatoverine 135mg tablets alleviate intestinal spasms.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from concurrent use of Gatoverine 135mg Tablet and alcohol.
PregnancyCONSULT YOUR DOCTOR
Using Gatoverine 135mg tablets during pregnancy poses a confirmed risk to the fetus and is therefore inadvisable. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingCONSULT YOUR DOCTOR
Data on Gatoverine 135mg Tablet use while breastfeeding is lacking. Seek medical advice from your physician.
DrivingSAFE
Driving ability is typically unaffected by Gatoverine 135mg Tablets.
KidneySAFE IF PRESCRIBED
The use of 135mg Gatoverine tablets in individuals with kidney impairment is likely safe. Current evidence indicates dose modification may be unnecessary, however, consultation with a physician is recommended. Patients exhibiting severe kidney disease should exercise caution.
LiverSAFE IF PRESCRIBED
The use of 135mg Gatoverine tablets in patients with liver impairment is likely safe. Available evidence indicates dose modification may be unnecessary; however, a physician's consultation is recommended. Patients with severe hepatic dysfunction should be treated with caution.
What if you forget to take Gatoverine 135mg Tablet :
Should you forget a Gatoverine 135mg Tablet dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Gatoverine 135mg Tablet
| Label | Value |
|---|---|
| Chemical Classification | Methoxybenzoic Acids and Related Compounds |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
| Active Class | Antispasmodic medications for inflammatory bowel disease (IBD) |
